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Abstract
Background: Leptospirosis is becoming a major public health threat in Sri Lanka as well as in other countries. We
designed a case control study to determine the factors associated with local transmission of leptospirosis in Sri
Lanka, in order to identify major modifiable determinants of leptospirosis. The purpose of this paper is to describe
the study protocol in detail prior to the publishing of the study results, so that the readership will be able to
understand and interpret the study results effectively.
Methods: A hospital based partially matched case control design is proposed. The study will be conducted in
three selected leptospirosis endemic districts in central Sri Lanka. Case selection will include screening all acute
fever patients admitted to selected wards to select probable cases of leptospirosis and case confirmation using an
array of standard laboratory criteria. Age and sex matched group of acute fever patients with other confirmed
diagnosis will be used as controls. Case to control ratio will be 1:2. A minimum sample of 144 cases is required to
detect 20% exposure with 95% two sided confidence level and 80% power. A pre tested interviewer administered
structured questionnaire will be used to collect data from participants. Variables included in the proposed study
will be evaluated using conceptual hierarch of variables in three levels; Exposure variables as proximal; reservoir
and environmental variables as intermediate; socio-demographic variables as distal. This conceptual hierarch
hypothesised that the distal and intermediate variables are mediated through the proximal variables but not
directly. A logistic regression model will be used to analyse the probable determinants of leptospirosis. This model
will evaluate the effect of same level and upper level variables on the outcome leptospirosis, using three blocks.
Discussion: The present national control programme of leptospirosis is hampered by lack of baseline data on
leptospirosis disease transmission. The present study will be able to provide these essential information for
formulation of better control strategies.
Background
Leptospirosis is thought to be the most widespread zoo-
notic disease in the world[1]. It poses a major public
health threat to the developing and the developed world
as an emerging infectious disease. Tens of millions of
people are estimated to be affected annually,[2] resulting
in 350,000 to 500,000 cases of severe disease[3]. The
disease is endemic in humid, tropical, and subtropical
areas of the world where most of the developing coun-
tries are located[4]. In Asia Pacific region, Latin America
and in Southeast Asia, it is highly prevalent[5] and there
has been a marked increase in the number of outbreaks
and cases reported during the last two decades. Even
though the disease is mostly endemic in rural settings,
[6] an increasing number of cases and frequent out-
breaks among urban dwellers[7,8] is a recent finding
worldwide.
The first confirmed case of leptospirosis was reported
in Sri Lanka in 1959[9]. Since then, series of confirmed
cases were reported from Gampaha, Kegalle, Ratnapura,
and Colombo districts during the 1960’s and 70’s. Disease
notification data shows a steady increase in reporting of
leptospirosis over the last two decades in Sri Lanka[10].
T h i sm a yb ee i t h e rd u et oe m e r g i n gd i s e a s eo rd u et o
improved surveillance or both. In 2007, clustering of uni-
dentified fever cases and few deaths were reported from
Matara, Gampaha and Kandy district and some of these
cases were later confirmed as leptospirosis. During 2008,
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pirosis in its history with 7406 reported cases[11].
Despite the fact that the Epidemiology Unit of Sri
Lanka predicted the 2008 outbreak correctly, the public
health system was unable to control the massive out-
break due to a scarcity of data. Previously, we reviewed
leptospirosis in Sri Lanka and explained the need for
confirmation of this outbreak through laboratory confir-
mation and the importance of investigating this prob-
able leptospirosis outbreak[12]. However, studies on the
epidemiology and determinants of local disease trans-
mission are lacking, whereas clinical manifestations are
discussed in several papers[13-15].
The global literature contains an extensive data base
on the epidemiology of leptospirosis. Most of these stu-
dies are retrospective, cross sectional descriptive analysis
of cases presenting during a specified time frame. Analy-
tical studies provide the best epidemiological tools in
determination and quantifying risk associations. Case
control studies are used in this type of diseases, because
they are cheap, rapid and easy to conduct. Cohort stu-
dies are unrealistic because of very low incidence rates
necessitating a very large study sample, which is not
cost effective. Analyses of risk factors of leptospirosis
have been attempted using case control methodology in
several studies[16-25]. Retrospective and prospective
studies are available and some studies are based on
cases identified through cross sectional antibody preva-
lence studies. Summary of published case control studies
of leptospirosis and identified risk factors are summar-
ized in Table 1.
As leptospirosis is becoming a major public health
threat in Sri Lanka, and data on local dynamics of dis-
ease transmission is lacking, we designed a case control
study to determine the factors associated with local
transmission of leptospirosis in Sri Lanka. The study
protocol was reviewed and approved by the Board of
Study in Community Medicine, Post Graduate Institute
of Medicine, Sri Lanka and Ethical Review Committee,
Faculty of Medicine, University of Peradeniya, Sri Lanka.
The study was conducted during the peak of the 2008
outbreak. The purpose of this paper is to describe the
study protocol in detail prior to the publishing of the
study results, so that the readership will be able to
understand and interpret the study results effectively.
Methods
Study design
This is a hospital based case control study.
Study settings
This study will be conducted in the districts of Kegalle,
Kandy, and Matale, in Sri Lanka. These three districts
are adjoining districts in the central part of the country
(Figure 1). The Kegalle district is situated in the Sabara-
gamuwa province and the other two districts are in the
Central province. All three districts have been declared
as leptospirosis endemic districts in Sri Lanka. Some
selected demographic and socio-economic indicators of
these three districts are listed in Table 2.
According to routinely reported data, the Kegalle dis-
trict had one of the highest incidence of leptospirosis in
Sri Lanka during the last five years. Kandy and Matale
districts show steadily increasing number of reported
cases during the same period which was also seen dur-
ing the present study period. All three districts reported
the highest number of cases in the history of Sri Lanka
during 2008. Matale district had the highest incidence
of leptospirosis in Sri Lanka during the 2008 outbreak.
Three main hospitals in these three selected districts
were selected for the present study. All three hospitals
are tertiary care units and sentinel sites selected for lep-
tospirosis surveillance by the Epidemiology Unit. Hospi-
tals selected for the present study are listed below.
1. District General Hospital-Kegalle (DGHK)
2. Teaching hospital - Kandy (THK)
3. District General Hospital - Matale (DGHM)
Study population
The study population will include all clinically suspected
leptospirosis patients who will be admitted to the medi-
cal wards in the selected government hospitals during
the study period. Patients in the paediatric age group
will not be included because the study needs invasive
procedure (acute and convalescent venous blood sam-
pling) with follow-up which will be difficult for children
as well as for parents.. In addition, data on exposure,
which will be the main determinant, will be difficult to
obtain from paediatric age group. Obtaining data from
parents on exposure will not be reliable and comparable
to adult patients.
Study sample
Cases
Cases for the present study will be selected after a
screening process and confirmatory tests. Recruiting
cases will be done prospectively. All fever cases admitted
to selected wards will initially be screened using the fol-
lowing inclusion criteria.
1. Patients admitted to medical wards in the selected
hospitals
2. Presenting complaint - acute febrile illness (fever
less than 15 days and temperature > 37.8°C)
3. One of the following major symptoms:
￿ Headache
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Authors Country Study Sample
size
Risk factors Odds ratio(CI)
Douglin et al (1997) St. Andrew Barbados Laboratory based
retrospective
Cases 22 Gardening 4.57(1.09-20.36)
Con. 38 presence of dogs around the home 7.82(1.79-46.55)
wearing boots in the garden or yard 8.59(1.93-42.55)
walking through ponds or stagnant water 25.62(2.89-
1151.84)
Bovet et al (1999) Seychellus Population based
prospective
Cases 75 Gardening 9.86 (2.6-36.1)
Con. 65 Indoor occupation 0.28 (0.09-0.85)
Home built with corrugated iron 4.6 (1.09-19.4)
Wet soil around home 5.65 (1.39-23)
Refuse not collected by public service 5.23 (1.37-20)
Cats at home 7.55 (2.04-27.9)
Skin wounds 6.66 (2.04-27.9)
Drinking locally made brew 5.41 (1.38-21.2)
Leal-Castellanos et al
(2003)
Chiapas, Mexico Rural community
prevalence study
1169
subjects
skin cut or abrasion 4.2 (3.1-5.7)
contact with animal excreta with no 1.9 (1.3-2.7)
protection and with a skin cut or abrasion 2.3 (1.1-4.6)
Phraisuwan et al (2002) Thailand High risk exposure
- after pond
cleaning
Cases 43 wearing long pants or skirts 0.217
Con. 61 presence of more than two wounds on the
body
3.97
Ashford et al (2000) Nicaragua High risk exposure
Following an
Outbreak
Case 85 Rural household 2.61 (1.06-6.45)
Con. 481 Gathering wood 2.08 (1.14-3.79)
Shelling/husking corn 1.8 (0.72-4.51)
Indoor water source 0.42 (0.22-0.80)
Everard et al Barbados Laboratory based
retrospective
Sugar-cane workers 5
(1990) those whose families minded livestock 2.5
rodents in their garden/yard 1.8
Johnson et al (2004) Peru Endemic area
seroprevalence
Case 235
Con. 1116
Not wearing shoes in the field 2.17 (1.39-3.37)
Tangkanakul et al (2000) North- eastern,
Thailand
Hospital based
Prospective
Case 56 travel on potholed roads 5.0 ( 1.2-20.2)
Con. 145 traveling by car 0.2 ( 0.06-0.9)
Sarkar et al (2002) Salvador, Brazil During an
epidemic
retrospective
population based
Case 101 Open sewer in proximity 5.07 (2.04-12.64)
Con. 125 Open sewer floods during rainy season 4.21 (1.51-12.83)
Street floods during rainy season 2.54 (1.08-6.17)
> 6 h/day outdoors 2.42 (1.16-5.00)
Contact with sewer water 3.63 (1.69-7.25)
Contact with floodwater 3.03 (1.44-6.39)
Contact with mud 3.08 (1.32-5.87)
Sighting groups of five or more rats 5.00 (2.22-21.25)
Peri-domiciliar sighting of rats Sighting 3.40 (1.74-11.78)
Sighting rats at work site 2.40 (1.11-5.17)
Dog as domestic animal 1.19 (0.57-2.47)
Works > 40 h/week 1.72 (0.89-3.66)
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￿ Prostration
4. Associated with any of the following signs (at least
one):
￿ Conjunctival suffusion/conjunctival
haemorrhage
￿ Meningeal irritation
￿ Anuria or oliguria/proteinuria/haematuria
￿ Jaundice
￿ Haemorrhages
￿ Purpuric skin rash
￿ Cardiac arrhythmia or failure
These inclusion criteria were formulated after an
extensive review of literature. The surveillance case defi-
nitions used in Sri Lanka by the national surveillance
programme[10] as well as case definitions used in other
countries were taken into consideration [26-37]. How-
ever, the suggested case definitions in other countries
and the surveillance case definition in Sri Lanka seemed
too stringent for the initial screening. Hence, the case
definitions were modified with the help of two experts
(A clinician and microbiologist) to increase the yield of
the screening, so that mild to moderate cases would
also be included in the selected study sample.
The second step of case selection will be the confir-
mation of screen positives. In Sri Lanka, recommended
leptospirosis diagnostic facilities are not available. The
available genus specific MAT performed at the Medical
Research Institute (MRI), Colombo is recommended
when no other options are available. This genus specific
test uses the patoc strain, which belongs to a saprophy-
tic, non-pathogenic Leptospira sp.T h i si sah i g h l yn o n -
specific test and is not included in the laboratory criteria
for leptospirosis diagnosis. Disease confirmation of all
the selected cases based on the gold standard criteria
(MAT) will not be possible in the present study due to
severe constraint of funds, logistic difficulties and non-
compliance of taking follow-up samples. A confirmed
case is defined according to the following criteria.
1. Sero-conversion or a significant increase in Lep-
tospira sp. agglutination titre;
Table 1: Risk factors for human leptospirosis based on case control studies (Continued)
Works outdoors exclusively 2.46 (1.04-5.11)
Work-related contact with trash 2.36 (1.23-5.56)
Nardone et al (1998) Metropolitan France Retrospective,
hospital-based
Case 90 Skin lesion 7.0 (2.7-17.6)
Con. 169 Countryside residence 2.9 (1.1-7.6)
Canoeing 15.5 (1.6-147.0)
Any animal contact 4.8 (1.4-16.2)
Figure 1 Map of Sri Lanka showing the study area.
Table 2 Selected demographic and socio-economic
characteristics of the study settings
Kandy Kegalle Matale
Total population 1,279,028 785,524 441,328
Land area (km
2) 1,940 1,693 1,993
Crude birth rate (per 1000 population) 22.4 11.5 16.7
Crude death rate (per 1000 population) 6.6 5.8 5
Median per capita income (Rupees) 16,203 13,114 14,119
Paddy harvested area (hectares) 30,752 25,070 14,598
Agampodi et al. BMC Infectious Diseases 2010, 10:332
http://www.biomedcentral.com/1471-2334/10/332
Page 4 of 9a. a MAT sero-conversion: negative first sample
and a titre of more than 1:100 in the second
sample
b. 4-fold rise in titre between acute and convales-
cent phase samples; OR
2. A single high Leptospira MAT titre greater than
or equal to 800; OR
3. Positive PCR; OR
4. A clinical case fulfilling stringent surveillance case
definition (surveillance case definition proposed by
WHO) and having a positive ELISA IgM test
Exclusion criteria
When the patient is critically ill and the accompanying
persons are unable to provide these details, those cases
will be excluded from the cases.
Controls
Inclusion criteria
Patients admitted to the same wards with a history of
fever, but with a confirmed diagnosis of diseases other
than leptospirosis will be selected as controls.
1. Patients admitted to medical wards in selected
hospitals
2. Presenting complaint - acute febrile illness (fever
less than 15 days)
3. Symptoms and signs not suggestive of leptospiro-
sis (not fulfilling the inclusion criteria as probable
cases during the first clinical screening)
4. Exclude leptospirosis by ELISA as described in
case definition
5. A laboratory confirmed diagnosis other than lep-
tospirosis as a cause for fever
Exclusion criteria
1. Critically ill patients who were unable to provide a
good exposure history
2. Patient whose diagnosis was ambiguous
For each case, two age and sex matched controls will
be selected. Age matching will be done within the range
of plus or minus five years.
Sample size
Sample size was calculated to detect association between
leptospirosis and exposure with 95% two sided confi-
dence level and 80% power. The formula suggested by
Fless and used in Open Epi, open source epidemiologic
statistical software for public health was used to calcu-
late the sample size.
Out of the variables selected, sample size calculation
was based on proximate variables because the concep-
tual framework hypothesized that distal variables are
mediated through proximate variables (see the vari-
ables). The lowest exposure rates among exposure
variables in normal population were estimated as 10%
and the exposure in the cases were estimated as 20%.
Based on these assumptions, the minimum sample size
required was 144 for each group. With adjustment for
probable non-respondent rate of 10%, the final sample
size required for the study was 158 cases and 316
controls.
Data collectors and training of data collectors
Data collectors will include PI and MBBS qualified
trained pre-intern medical officer. Recruitment of the
data collector was done after a screening process and an
interview. The selected data collector will undergo a
two-day training which had the following general objec-
tives.
Develop specific and general qualities for the role of
data collectors
Be made familiar with the study purpose, proce-
dures, and design
This training will thoroughly discuss the entire study
process from pre-data collection activities, actual data
collection and post data collection activities. The Data
c o l l e c t o rw i l lb eg i v e nac o m p r e h e n s i v ek n o w l e d g eo f
the entire study process.
Data collection instruments
An interviewer-administered questionnaire will be used
to collect data on co-determinants of human leptospiro-
sis. The questionnaire was formulated in English with a
translation to Sinhalese. Re-translation of the question-
naire was done to examine the validity of the translated
version.
Variables
Conceptual hierarchical framework of variable categories
Variables included in the study instrument were identi-
fied through extensive literature review and formal dis-
cussions with epidemiologists, microbiologists and
clinicians involved in leptospirosis disease prevention,
control and management.
The study is planned to evaluate the effects of the
postulated risk factors for human leptospirosis among
hospital admitted patients. These determinants were
chosen after an extensive literature review. The selected
determinants were grouped into hierarchical categories
according to the conceptual framework for determinants
of disease causation[38]. This categorization assumes
that each set of distal variable influences the level below
or the same level and the effect of the distal variable on
the disease is mediated through the proximate variables.
This conceptual model implies that demographic and
socio-economic variables may determine all variables
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the distal or parallel variables can confound the effect of
each variable. Since, the effects of distal variables are
mediated through proximate variables; lower level vari-
ables cannot be a confounder for upper level variables.
Factors that can be modifiable and those that can be
used for preventive and control strategies were included
in the list.
Outcome measure
The outcome measure will be the odds ratio associated
with various exposure risk factors.
Pre-testing of the study instrument
Pre-testing of the study instrument will be carried
out in order to,
￿ Determine the time length of the interview
￿ Improve the wording of the questions
￿ Eliminate unnecessary questions and add new
questions
￿ Test question sequence
￿ Correct and improve translation
￿ Identify conceptually vague items
￿ Formulate or interview aids to facilitate better
interviewing
￿ Check accuracy and adequacy of questionnaire
instructions
￿ Identify interviewers recoding difficulties.
Quality assurance measures
The quality assurance measures will be directed at con-
trolling bias, the interview technique, the preparation of
the fieldwork, the conduct of the study, and finally at
the plausibility of the database. Constant and close
supervision of data collection will ensure the quality of
data. More than 50% of data collection will be done by
direct supervision of the principal investigator. The PI
will visit each centre once in three days for direct super-
vision and during this visit; spot-checking and back
checking will be carried out.
After each interview, each data collector will go over
the questionnaire and check for consistency, accuracy
and completeness of data. Consistency checks will be
run during the data entry to improve the quality of data.
Range checks as well as skip and fill applications are
incorporated in to data entry programme to ensure that
encoded responses are within defined limits.
Control of bias
Bias and confounding factors can affect any observa-
tional study, especially in casec o n t r o ls t u d i e s .S e v e r a l
potential sources of biases were considered and mea-
sures will be taken to minimize those.
Recall bias
Recall bias is the differential recollection of exposure
between cases and controls. Study participants in the
present study will be patients from the same wards.
Laboratory confirmation of the disease status will not be
available for patients at the time of data collection
which will minimise recall bias in the study. Use of pro-
tocols and probing questions and training of data collec-
tor will also be done to minimise this bias.
Selection bias
Several forms of selection bias may occur in this type of
hospital based case control studies. Since the study will
be conducted during an epidemic period and all medical
Figure 2 Hierarchical framework of probable determinants of leptospirosis.
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exposure and leptospirosis, there is a possibility that
more patients with this specific exposure will be
admitted to the hospital. It might overestimate the final
effect size. However, selection of fever patients rather
than other patients of normal population as controls
will minimise this bias. Discussions will be held with all
clinicians and OPD doctors and the eligibility criteria
will be provided to them to reduce this bias to a mini-
mal level. Selection bias due to hospital selection will
occur if the controls are to be selected from the primary
study base (general population). It has been suggested
that for hospital based case control studies, using con-
trols with similar manifestations will minimise the selec-
tion bias [39-41] and present study will follow these
guidelines to minimise selection bias.
Interviewer bias
Interviewer bias is the differential collection of exposure
data from cases and controls by the interviewer. To
minimise this bias only two interviewers will be used in
this study. Both interviewers in the study will not be
a w a r eo ft h ef i n a ld i a g n o s i sa tt h et i m eo fd a t ac o l l e c -
tion. The clinical picture of study participants’ being
similar would minimize interviewer bias with the control
group. In addition, to minimise this effect, study proto-
cols and highly objective close ended questions will be
used in the study.
Confounding factors
Potential confounding factors for this study include
those known socio-demographic factors and environ-
mental factors. Some of the confounding factors will be
minimised in the present study using restriction of the
study population to adults admitted to particular hospi-
tals. Matching of age and sex for controls will minimise
the confounding effect of these known confounders.
Details of the other potential confounders will be
derived from the questionnaire and multivariate analysis
will be used to overcome the effect of these confounding
factors.
Quality of data
To improve the quality of data, following steps will be
taken.
￿ Blinding of the interviewers and patients on the
serological diagnosis
￿ Use of objectively oriented close ended questions
as much as possible
￿ Selecting incidence cases
￿ Training of data collectors
￿ Development of protocols and guidelines for data
collection and proper supervision by PI
Data processing and analysis
Data will be managed and analyzed using Epi-Info (ver-
sion 6.04: Centres for Disease Control and Prevention,
Atlanta, GA, USA) and Statistical Package for Social
Sciences (version 13.0: SPSS Inc., Chicago, IL, USA)
respectively.
All open-ended questions will be coded manually.
A codebook is prepared for all open and close-ended
questions in the study. The codebook contain the vari-
able names and their labels, the response categories and
their labels and codes for missing values. Data will be
entered manually as a double entry. During data entry,
automatic plausibility controls will be conducted to
assure quality of data entry. Descriptive statistics will be
computed for demographic variables for both cases and
controls.
Analysis of determinants will be done according to the
conceptual framework. Bivariate analysis of all determi-
nants and unadjusted odds ratios will be calculated first
to provide an overall idea about the probable determi-
nants. In the multivariate analysis, three models will be
used. In the first model, proximal variables will be
entered to the simple logistic regression model to assess
the overall effect of these variables. Odds ratios (ORs)
and their corresponding 95% confidence intervals will be
calculated for these variables. In the next model, inter-
mediate level variables will be entered to the model and
then proximal level variables will be added to evaluate
confounding effects of the intermediate level variables
on proximal variables. Remaining effects of proximal
level variables that is not mediated through intermediate
level variables will be reflected by corresponding OR for
proximal level variables. Risk factors significantly (P <
0.1) associated with outcome on each level will be
selected for inclusion in to next level. The confounding
effects will be detected through change in OR before
and after the adjustment for confounding variable. Final
set of risk factors are not the results from the full
model, which includes all variables, but from the equa-
tion corresponding to the level in which the variable is
first entered. This will avoid the possibility that the
more proximal determinants will remove the explana-
tory power of more distal determinants. Adjusted ORs
with a p value of < 0.05 will be interpreted as statisti-
cally significant association and p value > 0.05 and < 0.1
will be interpreted as having a trend for association.
Ethical considerations
Each potential respondent will be first provided with an
explanation of the purpose, nature time commitment
and potential benefits involved in participating in the
study, and will be given an assurance of confidentiality.
Each prospective participant will be given an opportu-
nity to ask any question regarding the study prior to
recruitment and during the study. Participants will be
provided with name and address of the principal investi-
gator to contact him any time during the study. Each
potential respondent will be free to decline participation
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Page 7 of 9and/or refuse to answer any specific question without
any loss of health care benefits or services. Informed
written consent will be obtained from all the patients
prior to recruitment.
All data collected in this study will be held in the
strictest confidence at all levels. Only the PI will have
access to collected data and data sets will bee stored in
a secure, password protected computer. The personal
data that will be collected will be used for only one pur-
pose; to send investigation reports to the patients.
Ethical clearance for the present study was obtained
from the Ethical Review Board of the Faculty of Medi-
cine, University of Peradeniya, Sri Lanka.
Results
Results of this study will be published in early 2011.
Discussion
The present situation of leptospirosis in Sri Lanka is a
major concern among public health professionals as well
as clinicians. Hence, the need for a national programme
of control and prevention of leptospirosis is urgent.
However, the preventive and control measures in Sri
Lanka are hampered by the lack of those essential base-
line data to understand leptospirosis disease dynamics in
the population To decide on proper control and preven-
tive measures determinants of local leptospirosis trans-
mission should be clearly defined. During outbreaks,
real time data collection is needed for better under-
standing of disease epidemiology. We discussed here the
rationale for the case control study on leptospirosis and
the details of the study protocol. If the determinants of
leptospirosis could be clearly identified through this
study, it will contribute greatly to control and preven-
tion program of leptospirosis in Sri Lanka.
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